SLMP53-1 |
Catalog No.GC65284 |
SLMP53-1 es un reactivador de p53 de tipo salvaje y mutante con actividad antitumoral prometedora. SLMP53-1 media la reprogramaciÓn del metabolismo de la glucosa en las células cancerosas. SLMP53-1 agota la angiogénesis, disminuyendo la formaciÓn de tubos de células endoteliales y los niveles de expresiÓn del factor de crecimiento endotelial vascular (VEGF).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1643469-17-3
Sample solution is provided at 25 µL, 10mM.
SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels[1][2].
[1]. Gomes S, et al. SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma. Cancers (Basel). 2019 Aug 10;11(8):1151.
[2]. Ramos H, et al. SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner. Int J Mol Sci. 2020 Jan 17;21(2):596.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *